2a4r

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2a4r" size="350" color="white" frame="true" align="right" spinBox="true" caption="2a4r, resolution 2.40&Aring;" /> '''HCV NS3 Protease Dom...)
Line 4: Line 4:
==Overview==
==Overview==
-
Modification of the P(2) and P(1) side chains of earlier P(3)-capped, alpha-ketoamide inhibitor of HCV NS3 serine protease 1 resulted in the, discovery of compound 24 with about 10-fold improvement in potency.
+
Modification of the P(2) and P(1) side chains of earlier P(3)-capped alpha-ketoamide inhibitor of HCV NS3 serine protease 1 resulted in the discovery of compound 24 with about 10-fold improvement in potency.
==About this Structure==
==About this Structure==
Line 19: Line 19:
[[Category: Gu, H.]]
[[Category: Gu, H.]]
[[Category: Madison, V.]]
[[Category: Madison, V.]]
-
[[Category: Njoroge, F.G.]]
+
[[Category: Njoroge, F G.]]
[[Category: Pichardo, J.]]
[[Category: Pichardo, J.]]
[[Category: Prongay, A.]]
[[Category: Prongay, A.]]
-
[[Category: Saksena, A.K.]]
+
[[Category: Saksena, A K.]]
[[Category: BNH]]
[[Category: BNH]]
[[Category: ZN]]
[[Category: ZN]]
[[Category: virus/viral protein]]
[[Category: virus/viral protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 17:54:25 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:23:35 2008''

Revision as of 14:23, 21 February 2008


2a4r, resolution 2.40Å

Drag the structure with the mouse to rotate

HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.

Overview

Modification of the P(2) and P(1) side chains of earlier P(3)-capped alpha-ketoamide inhibitor of HCV NS3 serine protease 1 resulted in the discovery of compound 24 with about 10-fold improvement in potency.

About this Structure

2A4R is a Protein complex structure of sequences from Hepatitis c virus with and as ligands. Full crystallographic information is available from OCA.

Reference

Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency., Bogen S, Saksena AK, Arasappan A, Gu H, Njoroge FG, Girijavallabhan V, Pichardo J, Butkiewicz N, Prongay A, Madison V, Bioorg Med Chem Lett. 2005 Oct 15;15(20):4515-9. PMID:16112862

Page seeded by OCA on Thu Feb 21 16:23:35 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools